Swiss National Bank’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.24M Hold
470,600
﹤0.01% 1455
2025
Q4
$8.58M Buy
470,600
+7,800
+2% +$131K 0.01% 1046
2025
Q3
$6.78M Buy
462,800
+8,800
+2% +$151K ﹤0.01% 1167
2025
Q2
$8.27M Sell
454,000
-4,400
-1% -$89.7K 0.01% 1018
2025
Q1
$9.09M Hold
458,400
0.01% 945
2024
Q4
$7.86M Buy
458,400
+28,500
+7% +$536K 0.01% 1063
2024
Q3
$8.59M Sell
429,900
-3,000
-0.7% -$46.7K 0.01% 1017
2024
Q2
$4.84M Buy
432,900
+11,800
+3% +$99K ﹤0.01% 1301
2024
Q1
$2.78M Hold
421,100
﹤0.01% 1648
2023
Q4
$1.9M Sell
421,100
-18,700
-4% -$69.2K ﹤0.01% 1869
2023
Q3
$1.57M Buy
439,800
+4,300
+1% +$16.6K ﹤0.01% 1983
2023
Q2
$1.61M Buy
435,500
+12,500
+3% +$46.3K ﹤0.01% 2032
2023
Q1
$1.4M Sell
423,000
-49,300
-10% -$170K ﹤0.01% 2052
2022
Q4
$1.83M Buy
+472,300
New +$1.46M ﹤0.01% 1948

Other funds holding ADMA